ACS Publications. Most Trusted. Most Cited. Most Read
PRC2 and SWI/SNF Chromatin Remodeling Complexes in Health and Disease
My Activity
    Current Topic

    PRC2 and SWI/SNF Chromatin Remodeling Complexes in Health and Disease
    Click to copy article linkArticle link copied!

    View Author Information
    Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, Massachusetts 02215, United States
    Epizyme Inc., 400 Technology Square, 4th floor, Cambridge, Massachusetts 02139, United States
    Other Access Options

    Biochemistry

    Cite this: Biochemistry 2016, 55, 11, 1600–1614
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.biochem.5b01191
    Published February 2, 2016
    Copyright © 2016 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    The dynamic structure of histones and DNA, also known as chromatin, is regulated by two classes of enzymes: those that mediate covalent modifications on either histone proteins or DNA and those that use the energy generated by ATP hydrolysis to mechanically alter chromatic structure. Both classes of enzymes are often found in large protein complexes. In this review, we describe two such complexes: polycomb repressive complex 2 (PRC2), with the protein methyltransferase EZH2 as its catalytic subunit, and the ATP-dependent chromatin remodeler switch/sucrose non-fermentable (SWI/SNF). EZH2 catalyzes the methylation of lysine 27 on histone H3, a covalent chromatin modification that is associated with repressed heterochromatin. The catalytic activity of SWI/SNF, in contrast, leads to a state of open chromatin associated with active transcription. In this review, we discuss the biochemical properties of both complexes, outline the principles of their regulation, and describe their opposing roles in normal development, which can be perturbed in disease settings such as cancer.

    Copyright © 2016 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Cited By

    Click to copy section linkSection link copied!

    This article is cited by 101 publications.

    1. Avinash Khanna, Alexandre Côté, Shilpi Arora, Ludivine Moine, Victor S. Gehling, Jehrod Brenneman, Nico Cantone, Jacob I. Stuckey, Shruti Apte, Ashwin Ramakrishnan, Kamil Bruderek, William D. Bradley, James E. Audia, Richard T. Cummings, Robert J. Sims III, Patrick Trojer, Julian R. Levell. Design, Synthesis, and Pharmacological Evaluation of Second Generation EZH2 Inhibitors with Long Residence Time. ACS Medicinal Chemistry Letters 2020, 11 (6) , 1205-1212. https://doi.org/10.1021/acsmedchemlett.0c00045
    2. Robert A. Copeland (Guest Editor). The Biochemistry of Chromatin Remodeling. Biochemistry 2016, 55 (11) , 1555-1556. https://doi.org/10.1021/acs.biochem.6b00014
    3. Anja Fischer, Thomas K. Albert, Natalia Moreno, Marta Interlandi, Jana Mormann, Selina Glaser, Paurnima Patil, Flavia W. de Faria, Mathis Richter, Archana Verma, Sebastian T. Balbach, Rabea Wagener, Susanne Bens, Sonja Dahlum, Carolin Göbel, Daniel Münter, Clara Inserte, Monika Graf, Eva Kremer, Viktoria Melcher, Gioia Di Stefano, Raffaella Santi, Alexander Chan, Ahmet Dogan, Jonathan Bush, Martin Hasselblatt, Sylvia Cheng, Signe Spetalen, Alexander Fosså, Wolfgang Hartmann, Heidi Herbrüggen, Stella Robert, Florian Oyen, Martin Dugas, Carolin Walter, Sarah Sandmann, Julian Varghese, Claudia Rossig, Ulrich Schüller, Alexandar Tzankov, Martin B. Pedersen, Francesco A. d’Amore, Karin Mellgren, Udo Kontny, Venkatesh Kancherla, Luis Veloza, Edoardo Missiaglia, Virginie Fataccioli, Philippe Gaulard, Birgit Burkhardt, Oliver Soehnlein, Wolfram Klapper, Laurence de Leval, Reiner Siebert, Kornelius Kerl. Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas. Nature Communications 2024, 15 (1) https://doi.org/10.1038/s41467-024-52826-0
    4. Xinghao Wang, Yajun Wang, Min Xie, Shichao Ma, Yilin Zhang, Lele Wang, Yangfeng Ge, Guobin Li, Mengxi Zhao, Sheng Chen, Chenxi Yan, Hailong Zhang, Wei Sun. Hypermethylation of CDKN2A CpG island drives resistance to PRC2 inhibitors in SWI/SNF loss-of-function tumors. Cell Death & Disease 2024, 15 (11) https://doi.org/10.1038/s41419-024-07109-3
    5. Prithviraj Rajebhosale, Alice Jone, Kory R. Johnson, Rohan Hofland, Camille Palarpalar, Samara Khan, Lorna W. Role, David A. Talmage. Neuregulin1 Nuclear Signaling Influences Adult Neurogenesis and Regulates a Schizophrenia Susceptibility Gene Network within the Mouse Dentate Gyrus. The Journal of Neuroscience 2024, 44 (43) , e0063242024. https://doi.org/10.1523/JNEUROSCI.0063-24.2024
    6. Louis-Alexandre Fournier, Forouh Kalantari, James P. Wells, Joon Seon Lee, Genny Trigo-Gonzalez, Michelle M. Moksa, Theodore Smith, Justin White, Alynn Shanks, Siyun L. Wang, Edmund Su, Yemin Wang, David G. Huntsman, Martin Hirst, Peter C. Stirling. Genome-Wide CRISPR Screen Identifies KEAP1 Perturbation as a Vulnerability of ARID1A-Deficient Cells. Cancers 2024, 16 (17) , 2949. https://doi.org/10.3390/cancers16172949
    7. Stefano Radaelli, Alessandra Merlini, Misbah Khan, Alessandro Gronchi. Progress in histology specific treatments in soft tissue sarcoma. Expert Review of Anticancer Therapy 2024, 24 (9) , 845-868. https://doi.org/10.1080/14737140.2024.2384584
    8. Patricia J. Keller, Elizabeth J. Adams, Rentian Wu, Alexandre Côté, Shilpi Arora, Nico Cantone, Rosana Meyer, Jennifer A. Mertz, Victor Gehling, Jike Cui, Jacob I. Stuckey, Avinash Khanna, Feng Zhao, Zehua Chen, Ziyang Yu, Richard T. Cummings, Mohammed Taimi, Nehal J. Lakhani, Drew Rasco, Martin Gutierrez, Linda Duska, Michael Devitt, Ronda Rippley, Julian Levell, Jennifer Truong, Jing Wang, Kaiming Sun, Patrick Trojer. Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers. Cancer Research 2024, 84 (15) , 2501-2517. https://doi.org/10.1158/0008-5472.CAN-24-0398
    9. Jin Cai, Haoyuan You, Xintong Qin, Yuhong Wang, Wei Li. Design, synthesis and activity evaluation of quinolinone derivatives as EZH2 inhibitors. Bioorganic & Medicinal Chemistry Letters 2024, 105 , 129726. https://doi.org/10.1016/j.bmcl.2024.129726
    10. Kamakoti P. Bhat, Jinchu Vijay, Caroline K. Vilas, Jyoti Asundi, Jun Zou, Ted Lau, Xiaoyu Cai, Musaddeque Ahmed, Michal Kabza, Julie Weng, Jean-Philippe Fortin, Aaron Lun, Steffen Durinck, Marc Hafner, Michael R. Costa, Xin Ye. CRISPR activation screens identify the SWI/SNF ATPases as suppressors of ferroptosis. Cell Reports 2024, 43 (6) , 114345. https://doi.org/10.1016/j.celrep.2024.114345
    11. Linxiang Zhang, Xueying Zhang, Yan Shi, Yuhan Ni, Jiaojiao Fei, Zhixin Jin, Wenjuan Li, Xiaojing Wang, Nan Wu. Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer. Frontiers in Oncology 2024, 14 https://doi.org/10.3389/fonc.2024.1376916
    12. Haley McConkey, Bekim Sadikovic. Epigenomic mechanisms and episignature biomarkers in rare diseases. 2024, 1031-1076. https://doi.org/10.1016/B978-0-443-21863-7.00012-3
    13. Wolfgang A. Schulz. Krebsepigenetik. 2024, 205-237. https://doi.org/10.1007/978-3-031-42806-7_8
    14. Govindarao Yedlapalli, Y. Ganesh Kumar. Optimization of Bioanalytical Liquid Chromatography - Tandem Mass Spectrometric Method for Quantification of Tazemetostat: An Epithelioid Sarcoma Treatment Drug in Human Plasma. 2023, 550-555. https://doi.org/10.1109/SMART59791.2023.10428339
    15. Atsushi Kihara, Yusuke Amano, Noriyoshi Fukushima, Hiroyuki Fujiwara, Toshiro Niki. H3K27me3 deficiency in dedifferentiated carcinoma and carcinosarcoma of the endometrium. Virchows Archiv 2023, 483 (6) , 885-890. https://doi.org/10.1007/s00428-023-03665-9
    16. Giulia Bastianello, Giancarlo Porcella, Galina V. Beznoussenko, Gururaj Kidiyoor, Flora Ascione, Qingsen Li, Angela Cattaneo, Vittoria Matafora, Andrea Disanza, Micaela Quarto, Alexander A. Mironov, Amanda Oldani, Sara Barozzi, Angela Bachi, Vincenzo Costanzo, Giorgio Scita, Marco Foiani. Cell stretching activates an ATM mechano-transduction pathway that remodels cytoskeleton and chromatin. Cell Reports 2023, 42 (12) , 113555. https://doi.org/10.1016/j.celrep.2023.113555
    17. Eugene E. Kim, Akshay Shekhar, Jayalakshmi Ramachandran, Alireza Khodadadi-Jamayran, Fang-Yu Liu, Jie Zhang, Glenn I. Fishman. The transcription factor EBF1 non-cell-autonomously regulates cardiac growth and differentiation. Development 2023, 150 (21) https://doi.org/10.1242/dev.202054
    18. Imran G. House, Emily B. Derrick, Kevin Sek, Amanda X.Y. Chen, Jasmine Li, Junyun Lai, Kirsten L. Todd, Isabelle Munoz, Jessica Michie, Cheok Weng Chan, Yu-Kuan Huang, Jack D. Chan, Emma V. Petley, Junming Tong, DatMinh Nguyen, Sven Engel, Peter Savas, Simon J. Hogg, Stephin J. Vervoort, Conor J. Kearney, Marian L. Burr, Enid Y.N. Lam, Omer Gilan, Sammy Bedoui, Ricky W. Johnstone, Mark A. Dawson, Sherene Loi, Phillip K. Darcy, Paul A. Beavis. CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity. Cell Reports 2023, 42 (8) , 113014. https://doi.org/10.1016/j.celrep.2023.113014
    19. Inga‐Marie Schaefer, Xiaohua Qian. The roles of the SWI/SNF complex in cancer. Cancer Cytopathology 2023, 131 (7) , 410-414. https://doi.org/10.1002/cncy.22691
    20. Yesim Bilmez, Saffet Ozturk. Dynamic changes of histone methylation in male germ cells during spermatogenesis. F&S Reviews 2023, 4 (3) , 187-205. https://doi.org/10.1016/j.xfnr.2023.07.001
    21. Jordan E. Otto, Oana Ursu, Alexander P. Wu, Evan B. Winter, Michael S. Cuoco, Sai Ma, Kristin Qian, Brittany C. Michel, Jason D. Buenrostro, Bonnie Berger, Aviv Regev, Cigall Kadoch. Structural and functional properties of mSWI/SNF chromatin remodeling complexes revealed through single-cell perturbation screens. Molecular Cell 2023, 83 (8) , 1350-1367.e7. https://doi.org/10.1016/j.molcel.2023.03.013
    22. Ted Kim, Nam Q. Bui. The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies. Cancers 2023, 15 (6) , 1692. https://doi.org/10.3390/cancers15061692
    23. Suman Kumar Ray, Sukhes Mukherjee. Starring Role of Biomarkers and Anticancer Agents as a Major Driver in Precision Medicine of Cancer Therapy. Current Molecular Medicine 2023, 23 (2) , 111-126. https://doi.org/10.2174/1566524022666211221152947
    24. Yumeng Tian, Lu Xu, Xin Li, Heming Li, Mingfang Zhao. SMARCA4: Current status and future perspectives in non-small-cell lung cancer. Cancer Letters 2023, 554 , 216022. https://doi.org/10.1016/j.canlet.2022.216022
    25. Sridhar M. Veluvolu, Patrick J. Grohar. Importance of pharmacologic considerations in the development of targeted anticancer agents for children. Current Opinion in Pediatrics 2023, 35 (1) , 91-96. https://doi.org/10.1097/MOP.0000000000001208
    26. Ssu-Yu Yeh, Ho Sung Rhee. The ChIP-Exo Method to Identify Genomic Locations of DNA-Binding Proteins at Near Single Base-Pair Resolution. 2023, 33-48. https://doi.org/10.1007/978-1-0716-2847-8_4
    27. Wolfgang A. Schulz. Cancer Epigenetics. 2023, 177-204. https://doi.org/10.1007/978-3-031-16286-2_8
    28. Aldo Manuel Alvarez Moran, Pablo Alejandro Ávila Sánchez, Jorge Alejandro Torres Ríos, Lorena Vega Castillo. Epigenomics in Malignant Pleural Mesothelioma. 2022https://doi.org/10.5772/intechopen.105408
    29. Carlos Jiménez, Roberta Antonelli, Mariona Nadal-Ribelles, Laura Devis-Jauregui, Pablo Latorre, Carme Solé, Marc Masanas, Adrià Molero-Valenzuela, Aroa Soriano, Josep Sánchez de Toledo, David Llobet-Navas, Josep Roma, Francesc Posas, Eulàlia de Nadal, Soledad Gallego, Lucas Moreno, Miguel F. Segura. Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program. Molecular Cancer 2022, 21 (1) https://doi.org/10.1186/s12943-022-01643-4
    30. Lena Wischhof, Hang‐Mao Lee, Janine Tutas, Clemens Overkott, Eileen Tedt, Miriam Stork, Michael Peitz, Oliver Brüstle, Thomas Ulas, Kristian Händler, Joachim L Schultze, Dan Ehninger, Pierluigi Nicotera, Paolo Salomoni, Daniele Bano. BCL7A ‐containing SWI/SNF/BAF complexes modulate mitochondrial bioenergetics during neural progenitor differentiation. The EMBO Journal 2022, 41 (23) https://doi.org/10.15252/embj.2022110595
    31. Antonio Marcondes Lerario, Dipika R Mohan, Gary D Hammer. Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies. Endocrine Reviews 2022, 43 (6) , 1051-1073. https://doi.org/10.1210/endrev/bnac012
    32. Ishita Baral, Pallavi Chinnu Varghese, Debasree Dutta. Epigenetics as “conductor” in “orchestra” of pluripotent states. Cell and Tissue Research 2022, 390 (2) , 141-172. https://doi.org/10.1007/s00441-022-03667-0
    33. Xi Zhang, Xiao Huo, Hongyan Guo, Lixiang Xue. Combined inhibition of PARP and EZH2 for cancer treatment: Current status, opportunities, and challenges. Frontiers in Pharmacology 2022, 13 https://doi.org/10.3389/fphar.2022.965244
    34. Elisa Del Savio, Roberta Maestro. Beyond SMARCB1 Loss: Recent Insights into the Pathobiology of Epithelioid Sarcoma. Cells 2022, 11 (17) , 2626. https://doi.org/10.3390/cells11172626
    35. Malin Lindén, Christoffer Vannas, Tobias Österlund, Lisa Andersson, Ayman Osman, Mandy Escobar, Henrik Fagman, Anders Ståhlberg, Pierre Åman. FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma. Molecular Oncology 2022, 16 (13) , 2470-2495. https://doi.org/10.1002/1878-0261.13195
    36. Enrique Fernández-Tabanera, Raquel M. Melero-Fernández de Mera, Javier Alonso. CD44 In Sarcomas: A Comprehensive Review and Future Perspectives. Frontiers in Oncology 2022, 12 https://doi.org/10.3389/fonc.2022.909450
    37. Chang Zhang, Hao Li. Molecular targeted therapies for pediatric atypical teratoid/rhabdoid tumors. Pediatric Investigation 2022, 6 (2) , 111-122. https://doi.org/10.1002/ped4.12325
    38. Chunming Guo, Yingsheng Zhang, Ruirong Tan, Zonghao Tang, Christa M. Lam, Xing Ye, Zhong Wang, Xue Li. Arid1a regulates bladder urothelium formation and maintenance. Developmental Biology 2022, 485 , 61-69. https://doi.org/10.1016/j.ydbio.2022.02.008
    39. Qiangsheng Zhang, Hongling Yang, Qiang Feng, Jiaying Cao, Yiqian Zhang, Lu Li, Luoting Yu. Focus on the classical and non-classical functions of EZH2: Guide the development of inhibitors and degraders. Pharmacological Research 2022, 178 , 106159. https://doi.org/10.1016/j.phrs.2022.106159
    40. Niannian Ding, Yuanyuan Chen, Yindi Chu, Cheng Zhong, Li Huang, Zhenfeng Zhang. Lysine Methylation Modulates the Interaction of Archaeal Chromatin Protein Cren7 With DNA. Frontiers in Microbiology 2022, 13 https://doi.org/10.3389/fmicb.2022.837737
    41. Qiangsheng Zhang, Xinyi Chen, Xi Hu, Xianjie Duan, Guoquan Wan, Lu Li, Qiang Feng, Yiqian Zhang, Ningyu Wang, Luoting Yu. Covalent inhibitors of EZH2: Design, synthesis and evaluation. Biomedicine & Pharmacotherapy 2022, 147 , 112617. https://doi.org/10.1016/j.biopha.2022.112617
    42. Yesim Bilmez, Gunel Talibova, Saffet Ozturk. Dynamic changes of histone methylation in mammalian oocytes and early embryos. Histochemistry and Cell Biology 2022, 157 (1) , 7-25. https://doi.org/10.1007/s00418-021-02036-2
    43. Katelyn E. Heimbruch, Joseph B. Fisher, Cary T. Stelloh, Emily Phillips, Michael H. Reimer, Adam J. Wargolet, Alison E. Meyer, Kirthi Pulakanti, Aaron D. Viny, Jessica J. Loppnow, Ross L. Levine, John Anto Pulikkan, Nan Zhu, Sridhar Rao. DOT1L inhibitors block abnormal self-renewal induced by cohesin loss. Scientific Reports 2021, 11 (1) https://doi.org/10.1038/s41598-021-86646-9
    44. Sijie Wang, Sandra C. Ordonez-Rubiano, Alisha Dhiman, Guanming Jiao, Brayden P Strohmier, Casey J Krusemark, Emily C Dykhuizen. Polycomb group proteins in cancer: multifaceted functions and strategies for modulation. NAR Cancer 2021, 3 (4) https://doi.org/10.1093/narcan/zcab039
    45. Florian Carlier, Tinh-Suong Nguyen, Alexey K. Mazur, Eugene Gladyshev. Modulation of C-to-T mutation by recombination-independent pairing of closely positioned DNA repeats. Biophysical Journal 2021, 120 (20) , 4325-4336. https://doi.org/10.1016/j.bpj.2021.09.014
    46. Ruth Hornbachner, Andreas Lackner, Henrieta Papuchova, Sandra Haider, Martin Knöfler, Karl Mechtler, Paulina A. Latos. MSX2 safeguards syncytiotrophoblast fate of human trophoblast stem cells. Proceedings of the National Academy of Sciences 2021, 118 (37) https://doi.org/10.1073/pnas.2105130118
    47. Karolina Pyziak, Agnieszka Sroka‐Porada, Tomasz Rzymski, Józef Dulak, Agnieszka Łoboda. Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation. Drug Development Research 2021, 82 (6) , 730-753. https://doi.org/10.1002/ddr.21796
    48. Inga-Marie Schaefer, Alyaa Al-Ibraheemi, Xiaohua Qian. Cytomorphologic Spectrum of SMARCB1-Deficient Soft Tissue Neoplasms. American Journal of Clinical Pathology 2021, 156 (2) , 229-245. https://doi.org/10.1093/ajcp/aqaa223
    49. Inga-Marie Schaefer, Jason L. Hornick. SWI/SNF complex-deficient soft tissue neoplasms: An update. Seminars in Diagnostic Pathology 2021, 38 (3) , 222-231. https://doi.org/10.1053/j.semdp.2020.05.005
    50. Noemi Simeone, Anna Maria Frezza, Nadia Zaffaroni, Silvia Stacchiotti. Tazemetostat for Advanced Epithelioid Sarcoma: Current Status and Future Perspectives. Future Oncology 2021, 17 (10) , 1253-1263. https://doi.org/10.2217/fon-2020-0781
    51. Jia Z. Shen, Zhixin Qiu, Qiulian Wu, Darren Finlay, Guillermina Garcia, Dahui Sun, Juha Rantala, William Barshop, Jennifer L. Hope, Ryan C. Gimple, Olle Sangfelt, Linda M. Bradley, James Wohlschlegel, Jeremy N. Rich, Charles Spruck. FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells. Cell 2021, 184 (2) , 352-369.e23. https://doi.org/10.1016/j.cell.2020.11.042
    52. Scott Barish, Tahsin Stefan Barakat, Brittany C. Michel, Nazar Mashtalir, Jennifer B. Phillips, Alfredo M. Valencia, Berrak Ugur, Jeremy Wegner, Tiana M. Scott, Brett Bostwick, David R. Murdock, Hongzheng Dai, Elena Perenthaler, Anita Nikoncuk, Marjon van Slegtenhorst, Alice S. Brooks, Boris Keren, Caroline Nava, Cyril Mignot, Jessica Douglas, Lance Rodan, Catherine Nowak, Sian Ellard, Karen Stals, Sally Ann Lynch, Marie Faoucher, Gaetan Lesca, Patrick Edery, Kendra L. Engleman, Dihong Zhou, Isabelle Thiffault, John Herriges, Jennifer Gass, Raymond J. Louie, Elliot Stolerman, Camerun Washington, Francesco Vetrini, Aiko Otsubo, Victoria M. Pratt, Erin Conboy, Kayla Treat, Nora Shannon, Jose Camacho, Emma Wakeling, Bo Yuan, Chun-An Chen, Jill A. Rosenfeld, Monte Westerfield, Michael Wangler, Shinya Yamamoto, Cigall Kadoch, Daryl A. Scott, Hugo J. Bellen. BICRA, a SWI/SNF Complex Member, Is Associated with BAF-Disorder Related Phenotypes in Humans and Model Organisms. The American Journal of Human Genetics 2020, 107 (6) , 1096-1112. https://doi.org/10.1016/j.ajhg.2020.11.003
    53. Katharina Leitner, Irina Tsibulak, Verena Wieser, Katharina Knoll, Daniel Reimer, Christian Marth, Heidi Fiegl, Alain G. Zeimet. Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer. Scientific Reports 2020, 10 (1) https://doi.org/10.1038/s41598-020-77532-x
    54. Brie E. Kezlarian, Oscar Lin, Snjezana Dogan. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization. Journal of the American Society of Cytopathology 2020, 9 (6) , 494-501. https://doi.org/10.1016/j.jasc.2020.07.134
    55. Rozenn Riou, Meriem Ladli, Sabine Gerbal-Chaloin, Pascale Bossard, Angélique Gougelet, Cécile Godard, Robin Loesch, Isabelle Lagoutte, Franck Lager, Julien Calderaro, Alexandre Dos Santos, Zhong Wang, Frédérique Verdier, Sabine Colnot. ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription. eLife 2020, 9 https://doi.org/10.7554/eLife.53550
    56. Darmood Wei, Youfeng Yang, Christopher J. Ricketts, Cathy D. Vocke, Mark W. Ball, Carole Sourbier, Darawalee Wangsa, Danny Wangsa, Rajarshi Guha, Xiaohu Zhang, Kelli Wilson, Lu Chen, Paul S. Meltzer, Thomas Ried, Craig J. Thomas, Maria J. Merino, W. Marston Linehan. Novel renal medullary carcinoma cell lines, UOK353 and UOK360 , provide preclinical tools to identify new therapeutic treatments. Genes, Chromosomes and Cancer 2020, 59 (8) , 472-483. https://doi.org/10.1002/gcc.22847
    57. Teresita Padilla-Benavides, Pablo Reyes-Gutierrez, Anthony N. Imbalzano. Regulation of the Mammalian SWI/SNF Family of Chromatin Remodeling Enzymes by Phosphorylation during Myogenesis. Biology 2020, 9 (7) , 152. https://doi.org/10.3390/biology9070152
    58. John B. Ridenour, Mareike Möller, Michael Freitag. Polycomb Repression without Bristles: Facultative Heterochromatin and Genome Stability in Fungi. Genes 2020, 11 (6) , 638. https://doi.org/10.3390/genes11060638
    59. Aniek van der Vaart, Molly Godfrey, Vincent Portegijs, Sander van den Heuvel. Dose-dependent functions of SWI/SNF BAF in permitting and inhibiting cell proliferation in vivo. Science Advances 2020, 6 (21) https://doi.org/10.1126/sciadv.aay3823
    60. Alexey K. Mazur, Tinh-Suong Nguyen, Eugene Gladyshev. Direct Homologous dsDNA–dsDNA Pairing: How, Where, and Why?. Journal of Molecular Biology 2020, 432 (3) , 737-744. https://doi.org/10.1016/j.jmb.2019.11.005
    61. Moyra Smith. Signals, epigenetics, regulation of gene expression. 2020, 109-138. https://doi.org/10.1016/B978-0-12-819613-7.00005-0
    62. Calixto-Hope G Lucas, Harish N Vasudevan, William C Chen, Stephen T Magill, Steve E Braunstein, Line Jacques, Sonika Dahiya, Fausto J Rodriguez, Andrew E Horvai, Arie Perry, Melike Pekmezci, David R Raleigh. Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival. Neuro-Oncology Advances 2020, 2 (1) https://doi.org/10.1093/noajnl/vdaa131
    63. Sungho Lee, Patrick J. Karas, Caroline C. Hadley, James C. Bayley V, A. Basit Khan, Ali Jalali, Alex D. Sweeney, Tiemo J. Klisch, Akash J. Patel. The Role of Merlin/NF2 Loss in Meningioma Biology. Cancers 2019, 11 (11) , 1633. https://doi.org/10.3390/cancers11111633
    64. Veronika Vymetalkova, Pavel Vodicka, Sona Vodenkova, Sergio Alonso, Regine Schneider-Stock. DNA methylation and chromatin modifiers in colorectal cancer. Molecular Aspects of Medicine 2019, 69 , 73-92. https://doi.org/10.1016/j.mam.2019.04.002
    65. Andy Rampersaud, Nicholas J Lodato, Aram Shin, David J Waxman. Widespread Epigenetic Changes to the Enhancer Landscape of Mouse Liver Induced by a Specific Xenobiotic Agonist Ligand of the Nuclear Receptor CAR. Toxicological Sciences 2019, 171 (2) , 315-338. https://doi.org/10.1093/toxsci/kfz148
    66. Anna Varizhuk, Ekaterina Isaakova, Galina Pozmogova. DNA G‐Quadruplexes (G4s) Modulate Epigenetic (Re)Programming and Chromatin Remodeling. BioEssays 2019, 41 (9) https://doi.org/10.1002/bies.201900091
    67. Alexander Pemov, Nancy F Hansen, Sivasish Sindiri, Rajesh Patidar, Christine S Higham, Eva Dombi, Markku M Miettinen, Patricia Fetsch, Hilde Brems, Settara C Chandrasekharappa, Kristine Jones, Bin Zhu, Jun S Wei, , , James C Mullikin, Margaret R Wallace, Javed Khan, Eric Legius, Brigitte C Widemann, Douglas R Stewart. Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1–associated atypical neurofibromas. Neuro-Oncology 2019, 21 (8) , 981-992. https://doi.org/10.1093/neuonc/noz028
    68. Sam C Wang, Ibrahim Nassour, Shu Xiao, Shuyuan Zhang, Xin Luo, Jeon Lee, Lin Li, Xuxu Sun, Liem H Nguyen, Jen-Chieh Chuang, Lan Peng, Scott Daigle, Jeanne Shen, Hao Zhu. SWI/SNF component ARID1A restrains pancreatic neoplasia formation. Gut 2019, 68 (7) , 1259-1270. https://doi.org/10.1136/gutjnl-2017-315490
    69. Junjun Jing, Jifan Feng, Jingyuan Li, Xia Han, Jinzhi He, Thach-Vu Ho, Jiahui Du, Xuedong Zhou, Mark Urata, Yang Chai. Antagonistic interaction between Ezh2 and Arid1a coordinates root patterning and development via Cdkn2a in mouse molars. eLife 2019, 8 https://doi.org/10.7554/eLife.46426
    70. Annette K. Brenner, Øystein Bruserud. Functional Toll-Like Receptors (TLRs) Are Expressed by a Majority of Primary Human Acute Myeloid Leukemia Cells and Inducibility of the TLR Signaling Pathway Is Associated with a More Favorable Phenotype. Cancers 2019, 11 (7) , 973. https://doi.org/10.3390/cancers11070973
    71. Zuli Wang, Shuang Liu, Yongguang Tao. Regulation of chromatin remodeling through RNA polymerase II stalling in the immune system. Molecular Immunology 2019, 108 , 75-80. https://doi.org/10.1016/j.molimm.2019.02.012
    72. Anna Maria Frezza, Laura Botta, Annalisa Trama, Angelo P. Dei Tos, Silvia Stacchiotti. Chordoma: update on disease, epidemiology, biology and medical therapies. Current Opinion in Oncology 2019, 31 (2) , 114-120. https://doi.org/10.1097/CCO.0000000000000502
    73. Wei-Lien Wang, Alexander J. Lazar. Applications of Molecular Testing to Differential Diagnosis. 2019, 513-556. https://doi.org/10.1016/B978-0-323-49714-5.00018-1
    74. Aldo Manuel Álvarez-Morán, Pablo Ávila-Sánchez. Panorama epigenético del mesotelioma pleural maligno. NCT Neumología y Cirugía de Tórax 2019, 78 (4) , 395-403. https://doi.org/10.35366/NT194H
    75. Serap Erkek, Pascal D. Johann, Martina A. Finetti, Yiannis Drosos, Hsien-Chao Chou, Marc Zapatka, Dominik Sturm, David T.W. Jones, Andrey Korshunov, Marina Rhyzova, Stephan Wolf, Jan-Philipp Mallm, Katja Beck, Olaf Witt, Andreas E. Kulozik, Michael C. Frühwald, Paul A. Northcott, Jan O. Korbel, Peter Lichter, Roland Eils, Amar Gajjar, Charles W.M. Roberts, Daniel Williamson, Martin Hasselblatt, Lukas Chavez, Stefan M. Pfister, Marcel Kool. Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation. Cancer Cell 2019, 35 (1) , 95-110.e8. https://doi.org/10.1016/j.ccell.2018.11.014
    76. Takaya Ichikawa, Yusuke Okuno, Yoshitaka Sato, Fumi Goshima, Hironori Yoshiyama, Teru Kanda, Hiroshi Kimura, Takayuki Murata, . Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells. mSphere 2018, 3 (6) https://doi.org/10.1128/mSphere.00478-18
    77. Joseph J. Caumanns, G. Bea A. Wisman, Katrien Berns, Ate G.J. van der Zee, Steven de Jong. ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018, 1870 (2) , 176-184. https://doi.org/10.1016/j.bbcan.2018.07.005
    78. Antonio Jordán-Pla, Simei Yu, Johan Waldholm, Thomas Källman, Ann-Kristin Östlund Farrants, Neus Visa. SWI/SNF regulates half of its targets without the need of ATP-driven nucleosome remodeling by Brahma. BMC Genomics 2018, 19 (1) https://doi.org/10.1186/s12864-018-4746-2
    79. Tanner C. Godfrey, Benjamin J. Wildman, Amjad Javed, Christopher J. Lengner, Mohammad Quamarul Hassan. Epigenetic remodeling and modification to preserve skeletogenesis in vivo. Connective Tissue Research 2018, 59 (sup1) , 52-54. https://doi.org/10.1080/03008207.2017.1408599
    80. Toria Trost, Jessica Haines, Austin Dillon, Brittany Mersman, Mallory Robbins, Peyton Thomas, Amy Hubert. Characterizing the role of SWI/SNF-related chromatin remodeling complexes in planarian regeneration and stem cell function. Stem Cell Research 2018, 32 , 91-103. https://doi.org/10.1016/j.scr.2018.09.004
    81. Yan-Hong Chen, Wen-jing Zeng, Zhi-peng Wen, Quan Cheng, Xiao-Ping Chen. Under explored epigenetic modulators: role in glioma chemotherapy. European Journal of Pharmacology 2018, 833 , 201-209. https://doi.org/10.1016/j.ejphar.2018.05.047
    82. Seong Won Lee, Young Mi Oh, Ya-Lin Lu, Woo Kyung Kim, Andrew S. Yoo. MicroRNAs Overcome Cell Fate Barrier by Reducing EZH2-Controlled REST Stability during Neuronal Conversion of Human Adult Fibroblasts. Developmental Cell 2018, 46 (1) , 73-84.e7. https://doi.org/10.1016/j.devcel.2018.06.007
    83. Heba Zayed, Iver Petersen. Stem cell transcription factor SOX2 in synovial sarcoma and other soft tissue tumors. Pathology - Research and Practice 2018, 214 (7) , 1000-1007. https://doi.org/10.1016/j.prp.2018.05.004
    84. Armelle Dufresne, Mehdi Brahmi, Marie Karanian, Jean-Yves Blay. Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours. Nature Reviews Clinical Oncology 2018, 15 (7) , 443-458. https://doi.org/10.1038/s41571-018-0012-4
    85. Antoine Italiano, Jean-Charles Soria, Maud Toulmonde, Jean-Marie Michot, Carlo Lucchesi, Andrea Varga, Jean-Michel Coindre, Stephen J Blakemore, Alicia Clawson, Benjamin Suttle, Alice A McDonald, Mark Woodruff, Scott Ribich, Eric Hedrick, Heike Keilhack, Blythe Thomson, Takashi Owa, Robert A Copeland, Peter T C Ho, Vincent Ribrag. Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study. The Lancet Oncology 2018, 19 (5) , 649-659. https://doi.org/10.1016/S1470-2045(18)30145-1
    86. David F. Tough, Inmaculada Rioja, Paul-Peter Tak, Rab K. Prinjha. The Epigenetics of Autoimmunity and Epigenetic Drug Discovery. 2018, 297-320. https://doi.org/10.1016/B978-0-12-809912-4.00015-5
    87. Erfan Aref-Eshghi, Laila C. Schenkel, Deanna Alexis Carere, David I. Rodenhiser, Bekim Sadikovic. Epigenomic Mechanisms of Human Developmental Disorders. 2018, 837-859. https://doi.org/10.1016/B978-0-12-812215-0.00027-3
    88. Vivek Shukla, Mahadev Rao, Hongen Zhang, Jeanette Beers, Darawalee Wangsa, Danny Wangsa, Floryne O. Buishand, Yonghong Wang, Zhiya Yu, Holly S. Stevenson, Emily S. Reardon, Kaitlin C. McLoughlin, Andrew S. Kaufman, Eden C. Payabyab, Julie A. Hong, Mary Zhang, Sean Davis, Daniel Edelman, Guokai Chen, Markku M. Miettinen, Nicholas P. Restifo, Thomas Ried, Paul A. Meltzer, David S. Schrump. ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer. Cancer Research 2017, 77 (22) , 6267-6281. https://doi.org/10.1158/0008-5472.CAN-17-0570
    89. Thomas Januario, Xiaofen Ye, Russell Bainer, Bruno Alicke, Tunde Smith, Benjamin Haley, Zora Modrusan, Stephen Gould, Robert L. Yauch. PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors. Proceedings of the National Academy of Sciences 2017, 114 (46) , 12249-12254. https://doi.org/10.1073/pnas.1703966114
    90. Robert T Nakayama, John L Pulice, Alfredo M Valencia, Matthew J McBride, Zachary M McKenzie, Mark A Gillespie, Wai Lim Ku, Mingxiang Teng, Kairong Cui, Robert T Williams, Seth H Cassel, He Qing, Christian J Widmer, George D Demetri, Rafael A Irizarry, Keji Zhao, Jeffrey A Ranish, Cigall Kadoch. SMARCB1 is required for widespread BAF complex–mediated activation of enhancers and bivalent promoters. Nature Genetics 2017, 49 (11) , 1613-1623. https://doi.org/10.1038/ng.3958
    91. John Wojcik, Kumarasen Cooper. Epigenetic Alterations in Bone and Soft Tissue Tumors. Advances in Anatomic Pathology 2017, 24 (6) , 362-371. https://doi.org/10.1097/PAP.0000000000000167
    92. Haolin Liu, Chao Wang, Schuyler Lee, Yu Deng, Matthew Wither, Sangphil Oh, Fangkun Ning, Carissa Dege, Qianqian Zhang, Xinjian Liu, Aaron M. Johnson, Jianye Zang, Zhongzhou Chen, Ralf Janknecht, Kirk Hansen, Philippa Marrack, Chuan-Yuan Li, John W. Kappler, James Hagman, Gongyi Zhang. Clipping of arginine-methylated histone tails by JMJD5 and JMJD7. Proceedings of the National Academy of Sciences 2017, 114 (37) https://doi.org/10.1073/pnas.1706831114
    93. Scott Ribich, Darren Harvey, Robert A. Copeland. Drug Discovery and Chemical Biology of Cancer Epigenetics. Cell Chemical Biology 2017, 24 (9) , 1120-1147. https://doi.org/10.1016/j.chembiol.2017.08.020
    94. Lina Wang, Zhiliang Xu, Muhammad Babar Khawar, Chao Liu, Wei Li. The histone codes for meiosis. Reproduction 2017, 154 (3) , R65-R79. https://doi.org/10.1530/REP-17-0153
    95. Sergio Gascón, Giacomo Masserdotti, Gianluca Luigi Russo, Magdalena Götz. Direct Neuronal Reprogramming: Achievements, Hurdles, and New Roads to Success. Cell Stem Cell 2017, 21 (1) , 18-34. https://doi.org/10.1016/j.stem.2017.06.011
    96. Suzanne Ackloo, Peter J. Brown, Susanne Müller. Chemical probes targeting epigenetic proteins: Applications beyond oncology. Epigenetics 2017, 12 (5) , 378-400. https://doi.org/10.1080/15592294.2017.1279371
    97. Sasha G. Burrowes, Nihal A. Salem, Alexander M. Tseng, Sridevi Balaraman, Marisa R. Pinson, Cadianna Garcia, Rajesh C. Miranda. The BAF (BRG1/BRM-Associated Factor) chromatin-remodeling complex exhibits ethanol sensitivity in fetal neural progenitor cells and regulates transcription at the miR-9-2 encoding gene locus. Alcohol 2017, 60 , 149-158. https://doi.org/10.1016/j.alcohol.2017.01.003
    98. David F Tough, Rab K Prinjha. Immune Disease-Associated Variants in Gene Enhancers Point to BET Epigenetic Mechanisms for Therapeutic Intervention. Epigenomics 2017, 9 (4) , 573-584. https://doi.org/10.2217/epi-2016-0144
    99. Andrzej Jerzmanowski, Rafal Archacki. Universal and Lineage-Specific Properties of Linker Histones and SWI/SNF-Chromatin Remodeling Complexes in Plants. 2017, 463-492. https://doi.org/10.1007/978-3-319-55520-1_23
    100. David F. Tough, Paul P. Tak, Alexander Tarakhovsky, Rab K. Prinjha. Epigenetic drug discovery: breaking through the immune barrier. Nature Reviews Drug Discovery 2016, 15 (12) , 835-853. https://doi.org/10.1038/nrd.2016.185
    Load all citations

    Biochemistry

    Cite this: Biochemistry 2016, 55, 11, 1600–1614
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.biochem.5b01191
    Published February 2, 2016
    Copyright © 2016 American Chemical Society

    Article Views

    6652

    Altmetric

    -

    Citations

    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.